Tumor-secreted galectin-3 suppresses antitumor response by inducing IL-10<sup>+</sup> B cells.

HR − HER2 + patients showed a trend toward higher Gal-3 levels after NAT, although this was not significant, partially due to the small sample size ( figure 7A ).

also in 53,322 other papers